Financials data is unavailable for this security.
View more
Year on year Uni-Bio Science Group Ltd grew revenues 10.08% from 440.32m to 484.72m while net income improved 84.04% from 38.51m to 70.88m.
Gross margin | 83.51% |
---|---|
Net profit margin | 19.44% |
Operating margin | 20.59% |
Return on assets | 24.76% |
---|---|
Return on equity | 36.79% |
Return on investment | 32.97% |
More ▼
Cash flow in HKDView more
In 2023, Uni-Bio Science Group Ltd increased its cash reserves by 31.58%, or 31.02m. The company earned 98.85m from its operations for a Cash Flow Margin of 20.39%. In addition the company generated 24.51m cash from financing while 76.14m was spent on investing.
Cash flow per share | 0.019 |
---|---|
Price/Cash flow per share | 3.99 |
Book value per share | 0.0514 |
---|---|
Tangible book value per share | 0.045 |
More ▼
Balance sheet in HKDView more
Current ratio | 2.50 |
---|---|
Quick ratio | 2.17 |
Total debt/total equity | 0.2932 |
---|---|
Total debt/total capital | 0.2267 |
More ▼
Growth rates in HKD
Year on year, growth in earnings per share excluding extraordinary items increased 84.13%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 59.76 |